ICAD iCAD | $3.42
| 4/17/2025 | Reiterated by | Laidlaw | Analyst Yale Jen | Buy -> Hold | | Low | View details for Laidlaw rating of iCAD (NASDAQ:ICAD) on 4/17/2025 |
SLNO Soleno Therapeutics | $74.86
-0.5% | 3/27/2025 | Target Raised by | Laidlaw | Analyst Yale Jen | Buy -> Buy | $75.00 -> $105.00 | High | View details for Laidlaw rating of Soleno Therapeutics (NASDAQ:SLNO) on 3/27/2025 |
NVCT Nuvectis Pharma | $9.96
-3.6% | 3/17/2025 | Initiated by | Laidlaw | Analyst Yale Jen | Buy | $19.00 | High | View details for Laidlaw rating of Nuvectis Pharma (NASDAQ:NVCT) on 3/17/2025 |
LFWD ReWalk Robotics | $1.41
-4.1% | 2/10/2025 | Initiated by | Laidlaw | Analyst Yale Jen | Buy | $10.00 | High | View details for Laidlaw rating of ReWalk Robotics (NASDAQ:LFWD) on 2/10/2025 |
ABVX ABIVAX Société Anonyme | $7.12
| 7/29/2024 | Initiated by | Laidlaw | - | Buy | $48.00 | Low | View details for Laidlaw rating of ABIVAX Société Anonyme (NASDAQ:ABVX) on 7/29/2024 |
MEIP MEI Pharma | $2.04
+2.0% | 7/23/2024 | Downgraded by | Laidlaw | - | Buy -> Hold | | Low | View details for Laidlaw rating of MEI Pharma (NASDAQ:MEIP) on 7/23/2024 |
AFMD Affimed | $1.00
+0.6% | 6/13/2024 | Target Raised by | Laidlaw | - | Buy | $15.00 -> $25.00 | Low | View details for Laidlaw rating of Affimed (NASDAQ:AFMD) on 6/13/2024 |
PHGE BiomX | $0.60
-18.9% | 5/28/2024 | Initiated by | Laidlaw | - | Buy | $25.00 | N/A | View details for Laidlaw rating of BiomX (NYSEMKT:PHGE) on 5/28/2024 |
INAB IN8bio | $0.17
-1.7% | 3/18/2024 | Initiated by | Laidlaw | - | Buy | $7.50 | Low | View details for Laidlaw rating of IN8bio (NASDAQ:INAB) on 3/18/2024 |
CING Cingulate | $4.21
+0.7% | 12/22/2023 | Downgraded by | Laidlaw | - | Buy -> Hold | | Low | View details for Laidlaw rating of Cingulate (NASDAQ:CING) on 12/22/2023 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
CING Cingulate | $4.21
+0.7% | 1/20/2022 | Initiated by | Laidlaw | - | Buy | $170.00 | High | View details for Laidlaw rating of Cingulate (NASDAQ:CING) on 1/20/2022 |
AFMD Affimed | $1.00
+0.6% | 8/9/2020 | Reiterated by | Laidlaw | - | Market Perform -> Buy | $100.00 | Medium | View details for Laidlaw rating of Affimed (NASDAQ:AFMD) on 8/9/2020 |
CRIS Curis | $2.11
+16.6% | 7/29/2020 | Initiated by | Laidlaw | - | Buy | $100.00 | Medium | View details for Laidlaw rating of Curis (NASDAQ:CRIS) on 7/29/2020 |
SLNO Soleno Therapeutics | $74.86
-0.5% | 6/5/2020 | Reiterated by | Laidlaw | Analyst Yale Jen | Buy | $150.00 | Low | View details for Laidlaw rating of Soleno Therapeutics (NASDAQ:SLNO) on 6/5/2020 |
DCTH Delcath Systems | $12.04
-1.3% | 6/1/2020 | Initiated by | Laidlaw | - | Buy | $19.00 | High | View details for Laidlaw rating of Delcath Systems (NASDAQ:DCTH) on 6/1/2020 |
ALDX Aldeyra Therapeutics | $2.65
-1.5% | 5/26/2020 | Reiterated by | Laidlaw | - | Buy | $30.00 | Low | View details for Laidlaw rating of Aldeyra Therapeutics (NASDAQ:ALDX) on 5/26/2020 |
SLNO Soleno Therapeutics | $74.86
-0.5% | 12/23/2019 | Initiated by | Laidlaw | Analyst Francois Brisebois | Buy | | High | View details for Laidlaw rating of Soleno Therapeutics (NASDAQ:SLNO) on 12/23/2019 |
EYPT EyePoint Pharmaceuticals | $6.82
+2.7% | 11/4/2019 | Initiated by | Laidlaw | - | Buy | $500.00 | High | View details for Laidlaw rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 11/4/2019 |
AVDL Avadel Pharmaceuticals | $8.89
+3.3% | 9/24/2019 | Target Raised by | Laidlaw | Analyst Francois Brisebois | Buy | $3.00 -> $6.00 | Low | View details for Laidlaw rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 9/24/2019 |
TLSA Tiziana Life Sciences | $1.36
+9.7% | 9/10/2019 | Target Set by | Laidlaw | Analyst Francois Brisebois | Buy | $20.00 | N/A | View details for Laidlaw rating of Tiziana Life Sciences (NASDAQ:TLSA) on 9/10/2019 |
EBS Emergent BioSolutions | $5.33
-2.2% | 9/4/2019 | Target Set by | Laidlaw | Analyst Francois Brisebois | Buy | $72.00 | Low | View details for Laidlaw rating of Emergent BioSolutions (NYSE:EBS) on 9/4/2019 |
CLSD Clearside Biomedical | $0.87
+2.4% | 8/13/2019 | Downgraded by | Laidlaw | - | Buy -> Hold | | Low | View details for Laidlaw rating of Clearside Biomedical (NASDAQ:CLSD) on 8/13/2019 |
AVDL Avadel Pharmaceuticals | $8.89
+3.3% | 8/12/2019 | Upgraded by | Laidlaw | Analyst Francois Brisebois | Hold -> Buy | $3.00 | Low | View details for Laidlaw rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 8/12/2019 |
SLNO Soleno Therapeutics | $74.86
-0.5% | 7/8/2019 | Initiated by | Laidlaw | - | Buy | $150.00 | High | View details for Laidlaw rating of Soleno Therapeutics (NASDAQ:SLNO) on 7/8/2019 |
AFMD Affimed | $1.00
+0.6% | 7/3/2019 | Target Set by | Laidlaw | Analyst Yale Jen | Buy | $100.00 | Low | View details for Laidlaw rating of Affimed (NASDAQ:AFMD) on 7/3/2019 |
HOTH Hoth Therapeutics | $0.90
+5.6% | 5/20/2019 | Initiated by | Laidlaw | - | Buy | $250.00 | Low | View details for Laidlaw rating of Hoth Therapeutics (NASDAQ:HOTH) on 5/20/2019 |
AVDL Avadel Pharmaceuticals | $8.89
+3.3% | 3/18/2019 | Target Set by | Laidlaw | Analyst Francois Brisebois | Hold | $2.00 | Medium | View details for Laidlaw rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 3/18/2019 |
BSGM BioSig Technologies | $1.03
+11.9% | 2/20/2019 | Target Set by | Laidlaw | Analyst Francois Brisebois | Buy | $110.00 | Medium | View details for Laidlaw rating of BioSig Technologies (NASDAQ:BSGM) on 2/20/2019 |
ARCT Arcturus Therapeutics | $12.81
-0.1% | 2/19/2019 | Initiated by | Laidlaw | - | Buy | | Low | View details for Laidlaw rating of Arcturus Therapeutics (NASDAQ:ARCT) on 2/19/2019 |
TLSA Tiziana Life Sciences | $1.36
+9.7% | 12/17/2018 | Initiated by | Laidlaw | - | Buy -> Buy | | High | View details for Laidlaw rating of Tiziana Life Sciences (NASDAQ:TLSA) on 12/17/2018 |
CLSD Clearside Biomedical | $0.87
+2.4% | 11/6/2018 | Target Set by | Laidlaw | Analyst Francois Brisebois | Buy | $5.00 | Low | View details for Laidlaw rating of Clearside Biomedical (NASDAQ:CLSD) on 11/6/2018 |
AVDL Avadel Pharmaceuticals | $8.89
+3.3% | 11/6/2018 | Downgraded by | Laidlaw | - | Buy -> Hold | $6.00 | High | View details for Laidlaw rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 11/6/2018 |
CLSD Clearside Biomedical | $0.87
+2.4% | 7/16/2018 | Initiated by | Laidlaw | - | Buy | $18.00 | High | View details for Laidlaw rating of Clearside Biomedical (NASDAQ:CLSD) on 7/16/2018 |
VKTX Viking Therapeutics | $28.87
+3.3% | 6/1/2018 | Target Raised by | Laidlaw | - | Buy | $10.00 -> $15.00 | High | View details for Laidlaw rating of Viking Therapeutics (NASDAQ:VKTX) on 6/1/2018 |
MEIP MEI Pharma | $2.04
+2.0% | 4/12/2018 | Initiated by | Laidlaw | - | Buy | $140.00 | High | View details for Laidlaw rating of MEI Pharma (NASDAQ:MEIP) on 4/12/2018 |
MRNS Marinus Pharmaceuticals | $0.55
-0.2% | 12/14/2017 | Initiated by | Laidlaw | - | Buy -> Buy | $72.00 | High | View details for Laidlaw rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 12/14/2017 |
FRX Fennec Pharmaceuticals | C$7.08
| 11/29/2017 | Initiated by | Laidlaw | - | Buy | C$22.00 | N/A | View details for Laidlaw rating of Fennec Pharmaceuticals (TSE:FRX) on 11/29/2017 |
FENC Fennec Pharmaceuticals | $6.04
-2.4% | 11/29/2017 | Initiated by | Laidlaw | - | Buy -> Buy | $22.00 | High | View details for Laidlaw rating of Fennec Pharmaceuticals (NASDAQ:FENC) on 11/29/2017 |
EYPT EyePoint Pharmaceuticals | $6.82
+2.7% | 11/8/2017 | Initiated by | Laidlaw | - | Buy | $500.00 | N/A | View details for Laidlaw rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 11/8/2017 |
DRRX DURECT | $0.60
-3.2% | 10/20/2017 | Target Lowered by | Laidlaw | - | Buy -> Buy | $30.00 -> $20.00 | N/A | View details for Laidlaw rating of DURECT (NASDAQ:DRRX) on 10/20/2017 |
Donald Trump is about to free crypto from its chains … (Ad) Sure enough, Bitcoin took off on the exact day Juan said it would.
It's up more than 40% since the election … surpassing $100,000 on Dec. 8 .…
Now Juan believes it could hit $150,000 … or higher in 2025. There's another coin he thinks could do even better. |
IONS Ionis Pharmaceuticals | $30.71
+3.0% | 8/14/2017 | Reiterated by | Laidlaw | - | Buy | $65.00 | Low | View details for Laidlaw rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 8/14/2017 |
ICAD iCAD | $3.42
| 7/25/2017 | Reiterated by | Laidlaw | - | Buy | $11.00 | Medium | View details for Laidlaw rating of iCAD (NASDAQ:ICAD) on 7/25/2017 |
OPK OPKO Health | $1.38
-1.4% | 1/3/2017 | Reiterated by | Laidlaw | - | Buy | $22.00 -> $19.00 | N/A | View details for Laidlaw rating of OPKO Health (NASDAQ:OPK) on 1/3/2017 |
IONS Ionis Pharmaceuticals | $30.71
+3.0% | 12/27/2016 | Target Raised by | Laidlaw | - | Buy | $59.00 -> $65.00 | N/A | View details for Laidlaw rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 12/27/2016 |
AXON Axon Enterprise | $613.30
+0.4% | 12/20/2016 | Initiated by | Laidlaw | - | Sell | $7.50 | N/A | View details for Laidlaw rating of Axon Enterprise (NASDAQ:AXON) on 12/20/2016 |
VKTX Viking Therapeutics | $28.87
+3.3% | 8/11/2016 | Target Lowered by | Laidlaw | - | Buy | $20.00 -> $10.00 | N/A | View details for Laidlaw rating of Viking Therapeutics (NASDAQ:VKTX) on 8/11/2016 |
AVDL Avadel Pharmaceuticals | $8.89
+3.3% | 1/21/2016 | Target Lowered by | Laidlaw | - | Buy | $30.00 -> $25.00 | N/A | View details for Laidlaw rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 1/21/2016 |
AFMD Affimed | $1.00
+0.6% | 12/10/2015 | Initiated by | Laidlaw | - | Buy | $150.00 | N/A | View details for Laidlaw rating of Affimed (NASDAQ:AFMD) on 12/10/2015 |
OPK OPKO Health | $1.38
-1.4% | 8/13/2015 | Initiated by | Laidlaw | - | Buy | $22.00 | N/A | View details for Laidlaw rating of OPKO Health (NASDAQ:OPK) on 8/13/2015 |
OPK OPKO Health | $1.38
-1.4% | 8/12/2015 | Initiated by | Laidlaw | - | Buy | $22.00 | N/A | View details for Laidlaw rating of OPKO Health (NASDAQ:OPK) on 8/12/2015 |
ALDX Aldeyra Therapeutics | $2.65
-1.5% | 1/26/2015 | Initiated by | Laidlaw | Analyst Yale Jen | Buy | $30.00 | N/A | View details for Laidlaw rating of Aldeyra Therapeutics (NASDAQ:ALDX) on 1/26/2015 |
IONS Ionis Pharmaceuticals | $30.71
+3.0% | 12/9/2014 | Target Raised by | Laidlaw | - | | $65.00 | N/A | View details for Laidlaw rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 12/9/2014 |
IONS Ionis Pharmaceuticals | $30.71
+3.0% | 11/25/2014 | Reiterated by | Laidlaw | - | Buy | | N/A | View details for Laidlaw rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 11/25/2014 |
IONS Ionis Pharmaceuticals | $30.71
+3.0% | 8/12/2014 | Initiated by | Laidlaw | - | Buy | $52.00 | N/A | View details for Laidlaw rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 8/12/2014 |
IOVA Iovance Biotherapeutics | $3.59
+0.8% | 6/30/2014 | Initiated by | Laidlaw | - | Buy | | N/A | View details for Laidlaw rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 6/30/2014 |
SSYS Stratasys | $9.44
-2.0% | 3/7/2014 | Initiated by | Laidlaw | - | Buy | $145.00 | N/A | View details for Laidlaw rating of Stratasys (NASDAQ:SSYS) on 3/7/2014 |
OMCL Omnicell | $31.26
-0.4% | 3/5/2014 | Target Raised by | Laidlaw | - | Buy | $29.00 -> $34.00 | N/A | View details for Laidlaw rating of Omnicell (NASDAQ:OMCL) on 3/5/2014 |
SRDX Surmodics | $28.01
-9.4% | 2/25/2014 | Initiated by | Laidlaw | - | Buy | $30.00 | N/A | View details for Laidlaw rating of Surmodics (NASDAQ:SRDX) on 2/25/2014 |
OMCL Omnicell | $31.26
-0.4% | 1/28/2014 | Target Raised by | Laidlaw | - | Buy | $27.00 -> $29.00 | N/A | View details for Laidlaw rating of Omnicell (NASDAQ:OMCL) on 1/28/2014 |
